Lyell Immunopharma, Inc. Common Stock LYEL
$15.43
+43.27%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | 10-Q | 2026-11-04 | View → |
| 8-K | 8-K | 2026-11-04 | View → |
| 8-K | 8-K | 2026-11-04 | View → |
| 4 | Insider transaction | 2026-10-13 | View → |
| 4 | Insider transaction | 2026-09-10 | View → |
| 4 | Insider transaction | 2026-09-10 | View → |
| 8-K | 8-K | 2026-09-10 | View → |
| 4 | Insider transaction | 2026-08-25 | View → |
| 4 | Insider transaction | 2026-08-25 | View → |
| 4 | Insider transaction | 2026-08-25 | View → |
| 4 | Insider transaction | 2026-08-11 | View → |
| 4 | Insider transaction | 2026-08-11 | View → |
| 4 | Insider transaction | 2026-08-11 | View → |
| 4 | Insider transaction | 2026-08-11 | View → |
| 10-Q | 10-Q | 2026-08-06 | View → |
| 8-K | 8-K | 2026-08-06 | View → |
| 4 | FORM 4 | 2026-07-27 | View → |
| 4 | FORM 4 | 2026-07-27 | View → |
| 4 | FORM 4 | 2026-07-20 | View → |
| 4 | FORM 4 | 2026-07-17 | View → |
| S-3 | S-3 | 2026-07-13 | View → |
| 4 | FORM 4 | 2026-07-01 | View → |
| 4 | Insider transaction | 2026-06-18 | View → |
| 4 | Insider transaction | 2026-06-15 | View → |
| 4 | Insider transaction | 2026-06-15 | View → |
| 4 | Insider transaction | 2026-06-15 | View → |
| 4 | Insider transaction | 2026-06-15 | View → |
| 8-K | 8-K | 2026-06-15 | View → |
| 4 | Insider transaction | 2026-06-12 | View → |
| 4 | Insider transaction | 2026-06-12 | View → |
| 4 | Insider transaction | 2026-06-12 | View → |
| 4 | Insider transaction | 2026-06-12 | View → |
| 4 | Insider transaction | 2026-06-12 | View → |
| 4 | Insider transaction | 2026-06-12 | View → |
| 4 | Insider transaction | 2026-06-12 | View → |
| 4 | Insider transaction | 2026-06-11 | View → |
| 10-Q | 10-Q | 2026-05-06 | View → |
| 8-K | 8-K | 2026-05-06 | View → |
| DEF 14A | DEF 14A | 2026-04-24 | View → |
| S-3 | S-3 | 2026-04-03 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $15.43
- Market Cap
- $263.92 million
- 52-Week Range
- $7.20 – $45.00
- Average Volume
- 183K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.